Overview

Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA

Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
Obese women are significantly more likely than their normal BMI counterparts to experience failure of orally-dosed emergency contraceptives. Our preliminary data provides evidence for testing a dose escalation strategy in an effort to provide improved efficacy from orally-dosed emergency contraceptives in obese women. More data is needed regarding emergency contraception containing ulipristal acetate. The overall project will be focused on both levonorgestrel (LNG) - and ulipristal acetate (UPA)-containing emergency contraception but this protocol registration is for the UPA aspect of the study procedures.
Phase:
Phase 4
Details
Lead Sponsor:
Oregon Health and Science University
Collaborator:
National Institutes of Health (NIH)
Treatments:
Ulipristal acetate